Press releases
- ViiV Healthcare announces analysis showing no antiretroviral therapy interruptions due to COVID-19 across its clinical development programme for investigational, long-acting cabotegravir and rilpivirine
- GSK presents positive clinical data on maternal and older adults RSV candidate vaccines
- ViiV Healthcare presents long-term switch data for Dovato demonstrating non-inferior efficacy in adults with HIV-1 and zero cases of virologic failure versus continuation of a 3-drug TAF-based regimen
Tweets from GSK US
-
GSKUS @GSKUS
The best way to help protect against flu is to #GetVaccinated each year. Our own Dr. Leonard Freeland, VP & Director, Scientific Affairs & Public Health, Vaccines is #leadingbyexample by getting his flu shot this week. 💉We are proud to#FightFluu along with@NFIDvacciness!
about 22 days ago
A
-
GSKUS @GSKUS
It’s time to #OvaryAct in honor of #OvarianCancerAwarenessMonth. Get to know the signs and symptoms of #ovariancancer, and if you’re experiencing any of them make sure to speak with your doctor. Watch the video below and learn more 👇gsk.to/2GhrHDrjd
about 22 days ago -
GSKUS @GSKUS
Following the events of #racialinjustice in the US, we’ve been focused on #listeningtounderstand to identify where we can do more and focus on the things that’ll drive change in our company. Hear more from Carla, our VP, Specialty Marketing, US Pharma. #TuesdayThoughts
about 22 days ago
